JNJ: Johnson & Johnson Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 480,178.20
Enterprise Value ($M) 504,994.20
Book Value ($M) 74,023.00
Book Value / Share 28.13
Price / Book 6.49
NCAV ($M) -43,222.00
NCAV / Share -16.43
Price / NCAV -11.11

Profitability (mra)
Return on Invested Capital (ROIC) 0.18
Return on Assets (ROA) 0.11
Return on Equity (ROE) 0.30

Liquidity (mrq)
Quick Ratio 1.14
Current Ratio 1.39

Balance Sheet (mrq) ($M)
Current Assets 60,424.00
Assets 178,355.00
Liabilities 103,646.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 93,775.00
Operating Income 24,547.00
Net Income 20,878.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 23,410.00
Cash from Investing -8,683.00
Cash from Financing -14,047.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A State Street Corp 5.51 0.67
02-10 13G/A Vanguard Group Inc 8.92 3.00
02-01 13G/A BlackRock Inc. 7.60 6.11

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-04-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-02-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 2, 2022 or ☐ Transition Report Pursuant to Section 13 or
2021-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-07-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-06-24 1,101,535 6,956,442 15.83
2022-06-23 1,468,991 8,195,758 17.92
2022-06-22 1,764,663 8,616,074 20.48
2022-06-21 656,218 5,234,622 12.54

(click for more detail)

(click for list of largest short owners)

Similar Companies
ELAT – Elanco Animal Health Incorporated 5.00% Tangible Equity Units GLS – Gelesis Holdings, Inc. Common Stock
GSK – GlaxoSmithKline plc LCI – Lannett Company, Inc.
LLY – Eli Lilly And Co


Financial data and stock pages provided by
Fintel.io